EyeControl is a pioneer of medical technology specializing in innovative communication solutions that address unmet healthcare needs.
We implement disruptive AI technologies that connect people and bridge information gaps,
facilitating better medical care and decision-making.
By the numbers
Lack of communication and disorientation are risk factors for Delirium, a mental disturbance resulting in confusion and reduced awareness.
EyeControl is creating a standard of care
for communication between ICU patients and medical staff that improves treatment accuracy and outcomes.
EyeControl-Med is a communication solution for healthcare facilities, enabling remote connectivity between patients who cannot speak, medical teams, and loved ones.
As patients transition through phases of awareness and consciousness, the platform’s communication features can be adjusted according to their needs. EyeControl-Med drives improved clinical outcomes via real-time analytics, and is revolutionizing the industry standard for medical communication.
EyeControl-Home is a comprehensive communication solution for patients transitioning from medical facilities to remote home care and other Locked-in individuals, who cannot speak. It improves quality of life by providing round-the-clock connectivity and freedom of expression.
Comprising an eye-tracking wearable and cloud-based platform that utilize adaptive, ML-based pattern recognition, eye gestures are analyzed and converted to real-time patient communication and actionable clinical data.
We aim to humanize healthcare by providing an industry-standard communication solution for acute care environments.
Our products drive improved clinical outcomes via real-time analytics, by empowering communication between patients, caregivers, and medical teams.
EyeControl was established in 2016 by co-founders, who all have personal connections to Locked-in individuals. Or Retzkin, CEO and Co-founder, joined together with Itai Kornberg, CTO and Co-founder, and Shay Rishoni (1966-2018), Co-founder and ALS patient, on a mission to give the Locked-in community the ability to communicate.
Their journey, addressing the communication needs of those living with ALS, evolved into an innovative ICU communication and monitoring solution.
The Venture Competition – 3rd Place
8200 (Israeli Intelligence Unit) Accelerator participants
United Nations – Letter of Support from the Special Envoy on Disability and Accessibility
2022 Israel Innovation Authority grants
GeekTime Next – 1st Place in the Future Technology category
Mass Challenge – Gold Winner
Winners of the ICI Competition
WeWork Creator Awards, Global Finals
WeWork Creator Awards, Tel Aviv – 1st Place in the Launch category
European Commission’s Horizon 2020 SME Instrument Phase-2 program
Israeli Ministry of Foreign Affairs – featured in Top 3 Israeli Life Changing Technology
VentureClash – 2nd Place
European Commission Innovation Radar Prize – Winners of Tech for Society category
Winners of the European Innovation Council ePitch for COVID-19 Solutions
European Innovation Council Accelerator program
Forbes Magazine “Small Giants”
A winner of The Genesis Prize and Start-Up Nation Central’s COVID-19 Innovations competition
Peres Heritage Initiative
International Design Award
Good Design Award
the latest from eyecontrol
The EyeControl device has received international recognition at two prestigious design competitions:
2021 International Design Awards & 2021 Good Design Award
Our company is partnering with Hartford HealthCare and Hartford Hospital, where EyeControl-Med is being used to restore communication with acute care patients.
We are incredibly proud to be among the Israeli winners honored in the European Union’s Horizon 2020 Framework Programme ‘Hamsa’ ceremony.
EyeControl was a proud gold sponsor of the 2022 IsrALS gala.
EyeControl to exhibit and share early clinical results at the American Delirium Society Conference, June 12-14, Indianapolis, IN